Qualigen
     

 
 
Innovative products
  • Sterile Ciprofloxacin Single-Dose Otic Solution
  • Sterile Ciprofloxacin & Fluconazole PVC infusion bags
  • Fast dissolving tablets (proprietary technology)

  •  
     
      Descargas
      Ciprofloxacin Single-Dose Otic Solution Publications

     
    Sterile Ciprofloxacin Single-Dose Otic Solution

     
     
     
     
     
     
     
     
     

     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     

    Acute otitis externa even when the status of the tympanic membrane is unknown.
    Chronic suppurative otitis media, the only approved otic solution for this indication; represents 85% of otitis prescriptions with an incidence of 1.5% of the adult population.
    Indicated also in paediatrics use (no systemic absorption).
    An excellent topical use alternative.
    Easy use-single dose units.
    Wide anti-bacterial spectrum with high efficacy for Pseudomonas and Staphylos.

    Sterile Ciprofloxacin & Fluconazole PVC infusion bags

     
     
     
     
     
     
     
     
     
  • Ease of use, convenient storage, 0 breakages.
  • No air entry during dispensing keeping the product fully sterile.

  • Fast dissolving tablets (proprietary technology)

     
     
     
     
     
     
     
     
     
  • Designed for conventional manufacturing and packaging technology.
  • Rapid disintegration, high mechanical strengh and good taste.
  • Spanish patent application filed: appl. Nº 200201440, priority June 10, 2002.

  •  
     
     
     

    Products protected by valid patents are developed with no commercial purposes. These products are under development or study for internal or experimental uses as permitted by the Art. 10.6 of the Directive 2001/83/EC amended by Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004.

    None of the products are offered for sale or supplied to countries in which these acts could be in conflict with valid patents.

    © All rights reserved. Invent Farma Group.